Bryan Duell, DO
Orthopaedic Surgery · Duncan, OKNPI 1376078543
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,539 with a category attached, or 67.8%. Pylant Medical accounts for 75.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $2,750 and has fallen 88.6% since, to $313 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in OK, where the typical reported total is $4,342.
Across 37 payments — averaging $95.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$3K
- Stryker$162
- AbbVie$153
- Johnson & Johnson$141
- Amgen$78
- Pacira Pharmaceuticals Incorporated$62
- plus $285 from 7 others
What the payments were for
- Food & beverage$1,13932%
- Education$2,40068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 6 | $2,657 |
| Stryker | 2 | $162 |
| AbbVie | 7 | $153 |
| Johnson & Johnson | 2 | $141 |
| Amgen(2 entities) | 4 | $78 |
| Pacira Pharmaceuticals Incorporated | 3 | $62 |
| P Bar Medical LLC | 3 | $62 |
| Vertex | 3 | $55 |
| Heron Therapeutics, Inc. | 2 | $48 |
| Dynasplint Systems Inc. | 1 | $36 |
| Smith+Nephew | 1 | $34 |
| Bioventus LLC | 2 | $33 |
| Solventum Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TFN-Advance$119
- GAMMA$110
How this compares
$3,539 in reported general payments places this provider in the 45th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 116 | $5,800 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 153 | $1,232 |
| Diclofenac Sodium | 66 | $742 |
| Oxycodone Hcl | 151 | $726 |
| Meloxicam | 56 | $209 |
| Cefadroxil | 24 | $173 |
| Ondansetron Hcl | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Duncan
- Yogesh MittalTulsa$6.6M
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Vytautas RingusNorman$272K
- Jason EmersonOklahoma City$189K
- Brian ChalkinTulsa$183K
- Ronald DumiganOklahoma City$169K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Charles WoodEdmond$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.